Publications

Nature Protocols Publication - Neurotechnology has the potential to revolutionize science and medicine, but it also raises serious ethical concerns, such as the misuse of neurodata. To protect personal neuroprivacy and ensure the responsible development of this field, we advocate for ethical and human rights guidelines, technical safeguards, and regulatory reforms.

In this article, the authors address some of the most pressing issues that stem from the relationship between the technological advancements of the twenty-first century and legal regulation. The development of neurotechnology and artificial intelligence (AI), while offering considerable opportunities for the betterment of social life, also poses unprecedented risks.

While the development of emergent neurotechnology and AI has therapeutic potential, it also raises various ethical and societal consequences, putting the mental privacy, identity and agency of citizens potentially at risk. As one approach to provide ethical guidelines to novel neurotechnologies, we propose a “Technocratic Oath,” as a pledge of simple, fundamental ethical core principles to be adopted by Neurotechnology developers and the industry.

A potential solution to ethical issues of neurotechnologies are “NeuroRights,” five new human rights devised to protect individuals in the face of new neurotechnologies. The NeuroRights include the right to personal identity, free-will, mental privacy, equal access to mental augmentation, and protection from algorithmic bias.

An article in Horizons (Journal of International Relations and Sustainable Development) explaining the state of Neurotechnologies today and a way forward that could implicate the United Nations

A new article published in Neuroethics, on recommendations to mitigate the negative consequences that could arise from the unregulated development or application of novel neurotechnologies.

Artificial intelligence and brain–computer interfaces must respect and preserve people's privacy, identity, agency and equality, say Rafael Yuste, Sara Goering and colleagues.